SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 39 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,000 | +33.3% | 2,000 | 0.0% | 0.00% | – |
| Q2 2023 | $3,000 | -25.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2023 | $4,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2022 | $4,000 | -20.0% | 2,000 | -33.3% | 0.00% | – |
| Q3 2022 | $5,000 | +66.7% | 3,000 | +50.0% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -100.0% | 2,000 | -100.0% | 0.00% | -100.0% |
| Q3 2021 | $9,245,000 | +308066.7% | 6,252,000 | +312500.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | -40.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2020 | $5,000 | +25.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -42.9% | 2,000 | -33.3% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -16.7% | 3,000 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | +50.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | -100.0% | 3,000 | -100.0% | 0.00% | -100.0% |
| Q2 2019 | $15,204,000 | +25.5% | 6,941,000 | +3.1% | 0.01% | +20.0% |
| Q1 2019 | $12,116,000 | – | 6,730,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
| Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
| Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
| Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
| RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
| Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |